Belgium· BE-AMP-SAM278074-00
Tarceva 150 mg
A erlotinib product containing erlotinib hydrochloride, registered in Belgium by Roche Registration. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Erlotinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EB02 (erlotinib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Erlotinib · ATC L01EB02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of erlotinib costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Erlotinib · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$102.78
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Erlotinib Hydrochloride
- Manufacturer
- Roche Registration
- Country
- Belgium (BE)
- ATC code
- L01EB02
- ATC class
- Erlotinib
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb2243848
- be_apb0782821
- be_apb3872744
- be_apb7723711
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
355 interactions on record for erlotinib.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erlotinib · interactions on record
355 records
- 14 severe
- 192 moderate
- 2 minor
- 147 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erlotinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsErlotinib Amarox 150 mg filmomhulde tablettenAmarox Pharma B.V.
- FinlandErlotinib AvansorAvansor Pharma Oy
- United StatesErlotinibArmas Pharmaceuticals Inc.
- FranceERLOTINIB BIOGARAN 150 mg, comprimé pelliculéBIOGARAN
- SwedenErlotinib Avansor 150 mg Filmdragerad tablettAvansor Pharma Oy
- SpainERLOTINIB CIPLA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGCipla Europe
- CzechiaERLOTINIB KRKAKrka, d.d., Novo mesto, Novo mesto
- PolandErlotinib KrkaKrka, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
- Cyprus · Erlotinib Remedica
- Czechia · Erlotinib Krka, Erlotinib Teva
- Germany · Erlotev, Erlotinib Axiromed
- Denmark · Erlotinib "stada", Erlotinib Krka
- Estonia · Erlotinib Viatris
- Spain · Erlotinib Sandoz, Erlotinib Tarbis
- Finland · Erlotinib Krka, Erlotinib Stada
- France · Erlotinib Biogaran, Erlotinib Eg
- United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
- Greece · Erlotinib Faran, Erlotinib Teva
- Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
- Hungary · Erlotinib Actavis, Erlotinib Krka
- Iceland · Erlotinib Krka, Erlotinib Teva
- Italy · Erlotinib Mylan, Erlotinib Sandoz
- Liechtenstein · Tarceva
- Lithuania · Erlotinib Viatris, Varlota
- Latvia · Erlotinib Sandoz, Erlotinib Viatris
- Netherlands · Erlotinib Accordpharma, Erlotinib Amarox
- Norway · Erlotinib Krka, Tarceva
- Poland · Erlotinib Zentiva
- Portugal · Erlotinib Mylan, Erlotinib Qritou
- Romania · Erlotinib Krka, Erlotinib Viatris
- Sweden · Erlotinib Krka, Erlotinib Medical Valley
- Slovenia · Erlotinib Krka, Erlotinib Teva
- Slovakia · Erlotinib Sandoz, Erlotinib Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1d73e7c-9d31-4866-9fdd-df7d62f81087 GET /v1/drugs/f1d73e7c-9d31-4866-9fdd-df7d62f81087?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tarceva 150 mg",
"name_fr": "Tarceva 150 mg",
"name_nl": "Tarceva 150 mg",
"amp_code": "SAM278074-00",
"strengths": [
"150.0000"
],
"pack_count": 2,
"substances": [
"Erlotinib Hydrochloride",
"Erlotinib",
"Lactose Monohydrate",
"Sodium Laurilsulfate",
"Sodium Starch Glycolate (Type A)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Erlotinib",
"authorisation_numbers": [
"EU/1/05/311/003"
]
}See everything about erlotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.